OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SUPM55

Supermax Corporation Bhd

Medical Equipment, Supplies & DistributionVerified

Supermax Corporation Bhd has a capital structure characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. However, the company's liquidity is rated as medium, and its free cash flow is negative at -477.2 million MYR, suggesting cash flow constraints. The current ratio of 4.38 implies strong short-term liquidity, but the negative operating cash flow of -15.4 million MYR and free cash flow of -477.2 million MYR highlight ongoing operational cash outflows. Profitability metrics are weak, with a return on equity of -3.55% and a return on assets of -3.29%. These figures are below the typical performance thresholds for the medical equipment and supplies industry, indicating underperformance relative to industry expectations. The company reported a net loss of 144.0 million MYR and an operating loss of 190.3 million MYR, further underscoring its financial challenges. Supermax's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases the company's exposure to sector-specific risks and regional economic fluctuations. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Historical revenue of 779.6 million MYR does not indicate a clear upward or downward trend, and the absence of forward-looking guidance makes it difficult to assess future performance. Risk factors include a medium liquidity risk due to negative free cash flow and a net cash position that is negative after subtracting total debt. The dilution risk is rated as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's financial performance and cash flow issues may necessitate future capital raising, which could introduce dilution pressure. Recent events include the filing of financial statements that reveal the company's operating and net losses, as well as its cash flow challenges. No recent earnings call transcripts or other disclosures have been provided to offer additional insight into the company's strategic direction or operational performance.

30-day price · SUPM-0.01 (-1.6%)
Low$0.30High$0.37Close$0.32As of29 May, 00:00 UTC
Profile
CompanySupermax Corporation Bhd
TickerSUPM.KL
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Supermax Corporation Bhd is a Malaysian healthcare services and equipment company that generates revenue primarily through the distribution of medical equipment and supplies.

Classification. Supermax is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Supermax Corporation Bhd has a capital structure characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. However, the company's liquidity is rated as medium, and its free cash flow is negative at -477.2 million MYR, suggesting cash flow constraints. The current ratio of 4.38 implies strong short-term liquidity, but the negative operating cash flow of -15.4 million MYR and free cash flow of -477.2 million MYR highlight ongoing operational cash outflows. Profitability metrics are weak, with a return on equity of -3.55% and a return on assets of -3.29%. These figures are below the typical performance thresholds for the medical equipment and supplies industry, indicating underperformance relative to industry expectations. The company reported a net loss of 144.0 million MYR and an operating loss of 190.3 million MYR, further underscoring its financial challenges. Supermax's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases the company's exposure to sector-specific risks and regional economic fluctuations. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Historical revenue of 779.6 million MYR does not indicate a clear upward or downward trend, and the absence of forward-looking guidance makes it difficult to assess future performance. Risk factors include a medium liquidity risk due to negative free cash flow and a net cash position that is negative after subtracting total debt. The dilution risk is rated as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's financial performance and cash flow issues may necessitate future capital raising, which could introduce dilution pressure. Recent events include the filing of financial statements that reveal the company's operating and net losses, as well as its cash flow challenges. No recent earnings call transcripts or other disclosures have been provided to offer additional insight into the company's strategic direction or operational performance.
Key takeaways
  • Supermax Corporation Bhd is experiencing significant financial distress, with negative operating and net income.
  • The company's liquidity is medium, and its free cash flow is negative, indicating cash flow constraints.
  • Profitability metrics are weak, with a return on equity and return on assets both in negative territory.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to sector-specific risks.
  • Growth trajectory is unclear, with no specific revenue growth projections provided.
  • Risk factors include liquidity and cash flow issues, with a low dilution risk currently.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$779.6M
Gross profit$185.0M
Operating income-$190.3M
Net income-$145.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$15.4M
CapEx-$405.8M
Free cash flow-$477.2M
Total assets$4.41B
Total liabilities$325.0M
Total equity$4.08B
Cash & equivalents
Long-term debt$151.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.08B
Net cash-$151.9M
Current ratio4.4
Debt/Equity0.0
ROA-3.3%
ROE-3.5%
Cash conversion11.0%
CapEx/Revenue-52.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricSUPMActivity
Op margin-24.4%3.9% medp25 -31.3% · p75 14.4%below median
Net margin-18.6%2.4% medp25 -30.5% · p75 11.1%below median
Gross margin23.7%46.7% medp25 28.2% · p75 63.1%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-52.1%-4.8% medp25 -11.6% · p75 -2.4%bottom quartile
Debt / equity4.0%17.9% medp25 2.7% · p75 52.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-19 11:35 UTC#e63561eb
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 14:56 UTCJob: 54c6e43e